Theravance Biopharma (TBPH) Shares Repurchased (2022 - 2024)
Historic Shares Repurchased for Theravance Biopharma (TBPH) over the last 3 years, with Q1 2024 value amounting to $445000.0.
- Theravance Biopharma's Shares Repurchased fell 9919.61% to $445000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $445000.0, marking a year-over-year decrease of 9977.42%. This contributed to the annual value of $445000.0 for FY2024, which is 9977.42% down from last year.
- Per Theravance Biopharma's latest filing, its Shares Repurchased stood at $445000.0 for Q1 2024, which was down 9919.61% from $30.3 million recorded in Q4 2023.
- Over the past 5 years, Theravance Biopharma's Shares Repurchased peaked at $80.5 million during Q2 2023, and registered a low of $445000.0 during Q1 2024.
- Moreover, its 3-year median value for Shares Repurchased was $32.8 million (2022), whereas its average is $38.7 million.
- In the last 5 years, Theravance Biopharma's Shares Repurchased plummeted by 1301.7% in 2023 and then tumbled by 9919.61% in 2024.
- Theravance Biopharma's Shares Repurchased (Quarter) stood at $34.8 million in 2022, then dropped by 13.02% to $30.3 million in 2023, then crashed by 98.53% to $445000.0 in 2024.
- Its last three reported values are $445000.0 in Q1 2024, $30.3 million for Q4 2023, and $30.9 million during Q3 2023.